MyAverix Finance
NS · Pharmaceuticals
IPCA Laboratories Ltd (IPCALAB)
Pharmaceuticals & Biotechnology
IPCA Laboratories Ltd (IPCALAB) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $411.00B, P/E ratio is 36.29, net margin is 11.1%, dividend yield is 0.12%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for IPCALAB
IPCA Laboratories Ltd (IPCALAB) — FAQ
What is IPCA Laboratories Ltd's market cap?
IPCA Laboratories Ltd (IPCALAB) has a reported market cap of $411.00B (data as of 2026-07-10).
What is IPCALAB's P/E ratio?
The price-to-earnings (P/E) ratio for IPCA Laboratories Ltd (IPCALAB) is 36.29 (data as of 2026-07-10).
Does IPCA Laboratories Ltd pay a dividend?
IPCA Laboratories Ltd (IPCALAB) shows a reported dividend yield of 0.12%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is IPCA Laboratories Ltd in?
IPCA Laboratories Ltd (IPCALAB) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is IPCALAB listed on?
IPCALAB is listed on NS.
What is IPCA Laboratories Ltd's net margin?
IPCA Laboratories Ltd (IPCALAB) reports a net margin of 11.1% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.